Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-17-053461

Chief Executive Officer sold 35,000 shares at $67.12 ($2,349,200)

  • Chief Executive Officer acquired 35,000 shares (option exercise)
  • Chief Executive Officer gave 500 shares (gift)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Schenkein David P Chief Executive Officer 2017-09-07 Gift −500 271,772 I
Schenkein David P Chief Executive Officer 2017-09-18 Option exercise +35,000 $0.30 $10,588 35,000 D
Schenkein David P Chief Executive Officer 2017-09-18 Sale −35,000 $67.12 $2,349,200 0 D
Derivatives
Schenkein David P Chief Executive Officer 2017-09-18 Option exercise · Stock option (right to buy) −35,000 118,656 D
Open-market sales · 35,000 sh · avg $67.12 · $2,349,200
Loading xslF345X03/doc4.xml…